Market revenue in 2023 | USD 96,780.3 million |
Market revenue in 2030 | USD 201,527.0 million |
Growth rate | 11% (CAGR from 2023 to 2030) |
Largest segment | Personalized nutrition & wellness |
Fastest growing segment | PM Therapeutics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PM Diagnostics, PM Therapeutics, Personalized Medical Care, Personalized Nutrition & Wellness |
Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Illumina Inc, Asure Software Inc, Abbott Laboratories, Danaos Corp, Exact Sciences Corp, Danaher Corp, Amgen Inc, Qiagen NV, Exagen Inc Ordinary Shares, Quest Diagnostics Inc, Biogen Inc, Genelux Corp, International Business Machines Corp, Genentech, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized medicine market will help companies and investors design strategic landscapes.
Personalized nutrition & wellness was the largest segment with a revenue share of 33.16% in 2023. Horizon Databook has segmented the Asia Pacific personalized medicine market based on pm diagnostics, pm therapeutics, personalized medical care, personalized nutrition & wellness covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of a large target population, growing collaborative initiatives between Western & Eastern market participants, and high market penetration of segments such as complementary & alternative medicine are among the major factors contributing to the relatively faster growth of the Asia Pacific personalized medicine market over the forecast period.
Genomic applications have allowed expansion in personalized health interventions in the Asia Pacific for developing targeted pharmaceuticals and personalized nutrition & nutritional genomics. Recently, the bioinformatics community has recognized the requirement to address computational challenges associated with genomics and postgenomics high-throughput technologies.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific personalized medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific personalized medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account